Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

NCT01442935 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Folinic Acid
DRUG: 5-FU
DRUG: Irinotecan
DRUG: Irinotecan
DRUG: Bevacizumab
DRUG: Cetuximab

Sponsor

UNICANCER